lev-os Managing Biospecimen Protocols
Why This Skill Exists
Biospecimen collection, processing, storage, and tracking are critical components of clinical trials and translational research. Poor specimen management — incorrect processing, broken cold chain, mislabeling, inadequate chain of custody — renders biomarker, pharmacokinetic, and pharmacodynamic data useless and can invalidate primary endpoints in studies where biospecimen-derived data drive regulatory decisions. This skill implements ISBER (International Society for Biological and Environmental Repositories) best practices, NCI Best Practices for Biospecimen Resources, CAP/CLIA laboratory requirements, and ICH-GCP documentation standards for biospecimen management in clinical research.
Checkpoint A — Intake and Scoping
Required Intake Questions
- What types of biospecimens are collected (blood — whole blood, serum, plasma, PBMCs; urine; tissue — fresh, frozen, FFPE; CSF; bone marrow; other)?
- What assays/analyses will be performed on the specimens (PK, PD biomarkers, genomics, flow cytometry, histopathology, ctDNA)?
- What are the processing requirements (centrifugation speed/time/temperature, aliquoting, fixation, stabilization)?
- What are the stability requirements and maximum processing windows (time from collection to processing)?
- Where are specimens analyzed (central lab, local lab, sponsor lab, academic core facility)?
- What shipping requirements apply (ambient, cold pack, dry ice, liquid nitrogen)?
- What labeling system is used (barcoded, RFID, manual)?
- What LIMS (Laboratory Information Management System) or sample-tracking database is used?
- Are there consent-specific restrictions on specimen use (current study only, future research, genetic analysis permitted)?
- What regulatory requirements apply (CLIA/CAP for US labs, ISO 15189, GLP for certain analyses)?
Required Source Documents
- Protocol (biospecimen collection section and Schedule of Assessments)
- Laboratory Manual (specimen-specific processing instructions)
- Central lab kit order form and shipping instructions
- Consent form (biospecimen and genetic-data clauses)
- Material Transfer Agreement (MTA) if specimens are shared between institutions
- LIMS user guide and access credentials
- Site-specific laboratory certifications (CLIA, CAP)
- Cold-chain monitoring equipment specifications
Step 1 — Design the Collection Protocol
For each specimen type, define the complete collection procedure:
Blood Specimens
| Parameter | Specification |
|---|---|
| Tube type | Specify color-top and anticoagulant (EDTA lavender, sodium heparin green, citrate blue, SST gold, PAXgene RNA) |
| Volume | Per tube and total per visit (do not exceed safe limits — typically 450 mL per 8-week period for adults) |
| Collection order | Follow CLSI H3-A6 order of draw to avoid cross-contamination |
| Fasting requirement | Specify if fasting is required and minimum fasting duration |
| Processing time | Maximum time from collection to processing (e.g., centrifuge within 30 minutes) |
| Centrifugation | Speed (×g, not RPM), duration, temperature (e.g., 1500 ×g, 10 min, 4°C) |
| Aliquoting | Number of aliquots, volume per aliquot, tube type for storage |
| Stabilization | Special handling (e.g., PAXgene tubes must be inverted 10×, stored upright at RT for 2 hours before freezing) |
Tissue Specimens
- Fresh-frozen: Snap-freeze in liquid nitrogen within X minutes of excision; maintain at −80°C or below
- FFPE: Fix in 10% neutral buffered formalin for 6-72 hours (specify exact duration per protocol); process and embed per standard histology protocols
- Document ischemia times (warm ischemia, cold ischemia) — these affect biomarker validity
Urine Specimens
- Spot vs. timed collection; preservative requirements; volume and aliquoting; temperature during collection
Other Specimens (CSF, bone marrow, saliva, stool)
- Specimen-specific collection devices, volumes, processing steps, and stability windows
Step 2 — Implement Labeling and Identification
Design a labeling system that ensures traceability from participant to analysis result:
- Label content: Unique specimen ID (linked to participant but de-identified), specimen type, collection date/time, visit number, aliquot number
- Label format: Pre-printed barcoded labels (2D barcode preferred); cryogenic labels for frozen specimens (must withstand −80°C or LN2 temperatures without degrading)
- ID linking: Specimen ID linked to participant ID in a secure, access-controlled database; de-identification per HIPAA and protocol consent requirements
- Label generation: Generate labels before the study visit; include extra labels for unplanned collections
- Verification: Two-person verification (collector + verifier) at point of collection — confirm participant identity and label match
- Relabeling procedures: If relabeling is ever required (damaged label), document the old and new IDs with date, reason, and personnel
Step 3 — Establish Chain of Custody
Document specimen custody at every handoff:
- Collection: Date, time, collector name/initials, participant ID, specimens collected
- Processing: Date, time, processor name, procedures performed (centrifugation parameters, aliquoting, freezing method)
- Storage: Date/time placed in storage, storage location (freezer ID, rack, box, position), temperature
- Retrieval: Date/time retrieved, requester, purpose, destination
- Shipping: Date shipped, carrier (FedEx, World Courier, CRYOPORT), tracking number, packaging type, temperature monitor included (data-logger ID)
- Receipt at destination: Date/time received, condition on arrival (temperature log review, visual inspection for thawing/damage), receiving personnel name
Maintain chain-of-custody logs per ICH-GCP requirements — these are essential documents for the Trial Master File.
Step 4 — Manage Storage and Cold Chain
Storage Requirements by Specimen Type
| Specimen | Temperature | Duration |
|---|---|---|
| Serum/plasma (short-term) | −20°C | Up to 30 days |
| Serum/plasma (long-term) | −80°C or below | Years |
| Whole blood (same-day processing) | Room temperature | <6 hours |
| PBMCs | Liquid nitrogen (−196°C) | Years |
| FFPE tissue | Room temperature | Years |
| Fresh-frozen tissue | −80°C or LN2 | Years |
| RNA (PAXgene) | −80°C after initial RT stabilization | Years |
Cold-Chain Monitoring
- Continuous temperature monitoring: Digital data-loggers on all research freezers (−20°C, −80°C) and LN2 tanks
- Alarm systems: Audible and remote alarms (email/SMS) for temperature excursions; define response times and escalation procedures
- Backup power: Freezers on emergency generator circuits; backup LN2 supply for cryogenic storage
- Excursion management: Document any temperature excursion (date, duration, max temperature reached, affected specimens, impact assessment, corrective action)
- Calibration: Annual calibration of temperature-monitoring equipment with documented certificates
Step 5 — Manage Shipping and Receiving
Outbound Shipping
- Packaging: IATA-compliant packaging for Category B biological substances (UN3373); use validated shipping containers with gel packs, dry ice, or LN2 dry shippers as required
- Documentation: Shipping manifest (specimen IDs, type, quantity), chain-of-custody transfer form, temperature monitor, required regulatory documents (import permits if international)
- Dry ice quantity: Calculate based on transit time + 24-hour buffer; document weight at time of packing
- Carrier selection: Validated courier with clinical-trial experience; priority/overnight service with tracking
- Scheduling: Ship Monday-Wednesday to avoid weekend delays (unless weekend delivery is guaranteed)
Inbound Receiving
- Inspection: Verify package integrity, remaining dry ice or cold-pack condition, temperature-logger reading
- Reconciliation: Match received specimens against shipping manifest; document discrepancies
- Condition assessment: Document any compromised specimens (thawed, hemolyzed, insufficient volume, broken container)
- Storage: Place in appropriate storage within 30 minutes of receipt; log in LIMS
Step 6 — Manage Specimen Lifecycle
Track specimens from collection through final disposition:
- Inventory management: Real-time LIMS tracking of every aliquot's location, status, and availability
- Testing/analysis requests: Formal requisition process with authorization, purpose, and specimen-return expectations
- Freeze-thaw tracking: Record every freeze-thaw cycle (minimize; most assays tolerate 1-3 cycles)
- Specimen depletion: Document when specimens are fully consumed; update inventory
- Retention period: Per protocol and regulatory requirements (typically 2 years after NDA approval or study termination; longer for pivotal biomarker samples)
- Destruction: Document destruction per protocol and consent; obtain sponsor authorization; use witnessed destruction with documentation
Checkpoint B — Biospecimen Protocol Review
- Collection procedures are specified for every specimen type at every visit
- Processing windows and parameters are defined (time, temperature, speed, duration)
- Labeling system ensures unique identification and traceability
- Chain-of-custody documentation covers every handoff point
- Storage temperatures are specified and continuously monitored
- Shipping procedures comply with IATA regulations for biological substances
- LIMS is configured for all specimen types and tracking requirements
- Temperature-excursion response procedures are documented and personnel are trained
- Consent covers all intended specimen uses (current study, future research, genetic analysis)
- Specimen retention and destruction timelines are defined
Quality Audit
- Specimen collection volumes do not exceed safe limits for participants
- All freezers and LN2 tanks have continuous monitoring with functioning alarms
- Chain-of-custody logs are complete for every specimen from collection through current status
- Shipping temperature logs confirm no cold-chain breaks during transit
- LIMS inventory matches physical inventory (verified by periodic audits)
- MTA is in place for any specimens transferred to external institutions
- Laboratory certifications (CLIA, CAP, ISO 15189) are current for all analyzing laboratories
- Specimen-related consent language matches actual specimen use
- All [VERIFY] flags have been resolved or escalated
Guidelines
- Never collect specimens without confirmed consent for the specific collection — biobank consent and clinical-trial consent may differ
- Processing time windows are non-negotiable for analyte stability — a PK sample processed outside the window produces unreliable data
- Cold-chain breaks must be investigated and documented immediately — do not assume specimens are unaffected without evidence
- Two-person verification at collection is a critical safety control — mislabeled specimens cannot be corrected
- Dry ice quantities must account for transit delays — always add a 24-hour buffer
- International specimen shipments require advance planning for import permits, customs clearance, and CITES regulations (if applicable)
- Specimen destruction requires sponsor authorization and documented witness — never discard research specimens without formal approval
- For genetic specimens, verify that the consent explicitly permits genetic/genomic analysis and specify data-return policies
- Mark any temperature excursion or specimen-integrity concern with [VERIFY] for laboratory-director and medical-monitor review
- This skill produces biospecimen-management protocols — laboratory validation, assay qualification, and result interpretation require qualified laboratory scientists